Market Summary — 14 May 2020

With markets apparently becoming tired in their post-COVID-crash reality, confusion reigns in many investors’ minds.  The market has, according to many observers, become detached from underlying economic realities.  Many companies have withdrawn their guidance for the second quarter and often for the rest of 2020.  That absence of visibility, coupled Read more

Market Summary — 7 May 2020

In a recent conference call, Canaccord’s Tony Dwyer ably summarized the current market situation in a single graph: According to Dwyer, the market remains in a no-man’s-land between unprecedented economic events and unprecedented fiscal and monetary stimulus.  In this “frustration” phase, we remain focused on our task at hand.  Put Read more

Healthcare: Haven In the Storm?

The COVID crisis is first and foremost a healthcare crisis, although it is having deep economic effects.  Predictably, in the market volatility caused by the pandemic, the healthcare sector has broadly outperformed; and within healthcare, biotechnology has performed even more strongly. Of course healthcare is a broad sector, comprising many Read more

COVID: The Global Response

We’ve been concentrating on the fiscal and monetary response to the coronavirus pandemic.  The responses are similar to the playbook developed in the wake of the Great Recession, but in scope and size, they are unprecedented. Our coverage has been primarily of the response of U.S. authorities so far.  This Read more

What Comes Next

Over the past several weeks, we have kept you informed about the monetary and fiscal stimulus being enacted in the United States in response to the coronavirus pandemic and the economic dislocation associated with it. The nature and extent of the economic slowdown caused by measures to combat the virus Read more